SNC
AZN icon

Stifel Nicolaus & Co’s AstraZeneca AZN Stock Holding History

Stifel Nicolaus & Co’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$3.15M Buy
60,710
+3,308
+6% +$166K 0.05% 342
2013
Q2 		$2.72M Buy
+57,402
New +$2.92M 0.05% 350

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
MAA
Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
SCCM
Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Stifel Nicolaus & Co's AZN Position: Q3 2013 in Review

Stifel Nicolaus & Co increased its AstraZeneca (AZN) stake by 5.8% in Q3 2013, buying an estimated $166K and bringing the position to 60,710 shares worth $3.15M. The position accounts for 0.05% of the portfolio, ranked #342.

Stifel Nicolaus & Co first reported a position in AZN in Q2 2013 and has held it in 2 quarters since. 343 funds tracked by Wall St. Rank hold AZN as of Q3 2013.

  • Stifel Nicolaus & Co held 60,710 shares of AstraZeneca worth $3.15M as of Q3 2013.
  • Stifel Nicolaus & Co bought 3,308 AstraZeneca shares in Q3 2013, an estimated $166K.
  • AstraZeneca made up 0.05% of Stifel Nicolaus & Co's portfolio in Q3 2013, its #342 holding.
  • Stifel Nicolaus & Co first reported a position in AstraZeneca in Q2 2013 and has held it in 2 quarters since.
  • 343 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2013.

Based on Stifel Nicolaus & Co's 13F filing for Q3 2013, filed 13 Nov 2013.